The Food and Drug Administration said Friday it intends to restrict access to GLP-1 drug ingredients used in nonapproved compounded weight-loss products and that Hims & Hers Health Inc. could face federal enforcement, a move the agency said is aimed at curbing mass-marketed …[#item_full_content]
DOJ Looks at State Policies on Transgender Inmates
Marzo 27, 2026
The Department of Justice said Thursday it has notified the governors of California and Maine that it will investigate their policies on housing transgender inmates
